+
Site Tour

Explore the Latest VHD Guideline Updates for Mitral and Tricuspid Regurgitation

See how clinical evidence has shaped TEER guideline recommendations for mitral and tricuspid regurgitation treatment.

Download

Related Resources

1-year VANTAGE TAVI outcomes in low/intermediate-risk patients

Demonstrated Outcomes. Life-Changing Intervention

Reduced HF Hospitalisation. Improved Quality of Life

Immediate Relief. Durable Benefits

A Defining Moment Has To Start Somewhere. Why Not With You?

Transcatheter tricuspid valve repair: Cases, tips and tricks

M-TEER: Best treatment strategies for FMR AND DMR

TRENDING TOPICS

1-year VANTAGE TAVI outcomes in low/intermediate-risk patients

What are the learnings from the one-year VANTAGE TAVI outcomes in low/intermediate-risk patients?

Reduced HF Hospitalisation. Improved Quality of Life

MitraClip™ TEER Reduces HF Hospitalisations and Improves Patient Outcomes

Demonstrated Outcomes. Life-Changing Intervention

MitraClip™ TEER Delivers Proven Clinical Outcomes Across Diverse Patient Populations

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline